Literature DB >> 11574891

The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita.

T Vulliamy1, A Marrone, F Goldman, A Dearlove, M Bessler, P J Mason, I Dokal.   

Abstract

Dyskeratosis congenita is a progressive bone-marrow failure syndrome that is characterized by abnormal skin pigmentation, leukoplakia and nail dystrophy. X-linked, autosomal recessive and autosomal dominant inheritance have been found in different pedigrees. The X-linked form of the disease is due to mutations in the gene DKC1 in band 2, sub-band 8 of the long arm of the X chromosome (ref. 3). The affected protein, dyskerin, is a nucleolar protein that is found associated with the H/ACA class of small nucleolar RNAs and is involved in pseudo-uridylation of specific residues of ribosomal RNA. Dyskerin is also associated with telomerase RNA (hTR), which contains a H/ACA consensus sequence. Here we map the gene responsible for dyskeratosis congenita in a large pedigree with autosomal dominant inheritance. Affected members of this family have an 821-base-pair deletion on chromosome 3q that removes the 3' 74 bases of hTR. Mutations in hTR were found in two other families with autosomal dominant dyskeratosis congenita.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11574891     DOI: 10.1038/35096585

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  317 in total

Review 1.  Natural and pharmacological regulation of telomerase.

Authors:  Jean-Louis Mergny; Jean-François Riou; Patrick Mailliet; Marie-Paule Teulade-Fichou; Eric Gilson
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

2.  Preferential maintenance of critically short telomeres in mammalian cells heterozygous for mTert.

Authors:  Yie Liu; Hue Kha; Mark Ungrin; Murray O Robinson; Lea Harrington
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

Review 3.  Telomerase and idiopathic pulmonary fibrosis.

Authors:  Mary Armanios
Journal:  Mutat Res       Date:  2011-11-04       Impact factor: 2.433

4.  A role for a novel 'trans-pseudoknot' RNA-RNA interaction in the functional dimerization of human telomerase.

Authors:  Hinh Ly; Lifeng Xu; Melissa A Rivera; Tristram G Parslow; Elizabeth H Blackburn
Journal:  Genes Dev       Date:  2003-05-01       Impact factor: 11.361

5.  Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells.

Authors:  A Satyanarayana; S U Wiemann; J Buer; J Lauber; K E J Dittmar; T Wüstefeld; M A Blasco; M P Manns; K L Rudolph
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

6.  Biogenesis of yeast telomerase depends on the importin mtr10.

Authors:  Francisco Ferrezuelo; Barbara Steiner; Martí Aldea; Bruce Futcher
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

Review 7.  Prospects and challenges of building a cancer vaccine targeting telomerase.

Authors:  Robert H Vonderheide
Journal:  Biochimie       Date:  2007-07-17       Impact factor: 4.079

8.  Increased p53 activity does not accelerate telomere-driven ageing.

Authors:  Isabel García-Cao; Marta García-Cao; Antonia Tomás-Loba; Juan Martín-Caballero; Juana M Flores; Peter Klatt; María A Blasco; Manuel Serrano
Journal:  EMBO Rep       Date:  2006-03-31       Impact factor: 8.807

9.  No attenuation of the ATM-dependent DNA damage response in murine telomerase-deficient cells.

Authors:  Natalie Erdmann; Lea A Harrington
Journal:  DNA Repair (Amst)       Date:  2008-12-25

10.  Accelerated telomere shortening in response to life stress.

Authors:  Elissa S Epel; Elizabeth H Blackburn; Jue Lin; Firdaus S Dhabhar; Nancy E Adler; Jason D Morrow; Richard M Cawthon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.